STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3394 by analyst upside · 2026-08-13
HUM
Humana Inc.
Healthcare · Market Cap $47B · P/E 36.7x
ANALYST PRICE TARGET
+7.1%
implied upside to consensus target
Current Price $388.83
Consensus Target $416.43
Bull Target $513.0
Bear Target $280.0
Analysts Covering 23
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
10
Hold
12
Sell
0
52-Week Low $163.11
52-Week High $428.88
YTD Return +48.1%
FUNDAMENTALS
Market Cap $47B
P/E Ratio (TTM) 36.7x
Forward P/E 23.5x
EPS (TTM) $10.59
PEG Ratio 2.18
Dividend Yield 0.95%
Revenue (TTM) $145.7B
Profit Margin 0.9%
52-WEEK RANGE
52-Week Low $163.11
52-Week High $428.88
Current Price $388.83
Bear Target $280.0
Bull Target $513.0
● Now $388.83 ● Target $416.43
TRADING DATA
Avg Volume 1.5M
YTD Return +48.1%
Analyst Count 23
Consensus Buy
Upside to Target +7.1%
Last Updated 2026-08-13

ANALYST SUMMARY

Humana Inc. (HUM) is currently trading at $388.83 with a Wall Street consensus price target of $416.43, implying potential upside of 7.1% over the next 12 months. 23 analysts currently cover HUM, with a consensus rating of Buy - 48% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $513.0, while the most cautious has a target of $280.0.

HUM operates in the Healthcare sector with a market capitalisation of $47B. The stock is up 48.1% year-to-date and is currently trading near the upper end of its 52-week range of $163.11 – $428.88.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for HUM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Evercore ISI Group - Reiterated
In-Line → In-Line 2026-06-11 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-06-08 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-06-08 43% win rate (7 calls)
B of A Securities - Reiterated
Neutral → Neutral 2026-06-04 Building track record
Morgan Stanley - Reiterated
Underweight → Underweight 2026-06-04 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-06-01 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-26 Building track record
UBS - Reiterated
Neutral → Neutral 2026-05-22 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
49
out of 100
Coverage depth
24/30
Consensus clarity
18/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →